|
Home »
Shop » Sales
& Marketing
Sales & Marketing
Sales &
Marketing
Mobile and
Wireless Sales Force Strategies
Published by: KeywordPharma
Price:
£40.00
The dust seems to be settling in the mobile communications
world after several years of upheaval. The mobile revolution seemed to take
everyone by surprise, probably because it was an evolution rather than a
revolution. Unlike the web, which was hyped to the skies in the late 1990s (by
the current author among others!), mobile sales tools evolved from standalone
laptops to more convenient PDAs (personal data assistants) to a wireless set up
that enables representatives to take pre-sales information and file post-sales
call reports on the move. [read more |
buy it]
Medical Sales Rep Assessment: Shoot the Messenger, the Message,
or Both?
Published by:
Price:
Getting sales representatives
in front of doctors is still the most effective way to present the "story" of a
drug, according to Hank McKinnell, CEO of Pfizer. The story is the marketing
messages contained in the detail aid and talking points that sales reps use
when calling upon physicians. Getting the story right and delivering it
effectively is more important than ever and it is crucial that sales reps get
proper training.
This article is a review of Metamorph, Inc.'s
methodology of using specially trained physicians to assess and validate sales
strategy, marketing messages and sales aids of pharmaceutical companies based
on real-time calls with reps using a standardised set of data points. [read more |
buy
it]
Online Marketing
and eDetailing
Published by:
Price:
After a decade of
e-marketing and e-detailing, which included much hype and expectation, the dust
is beginning to settle on a phase of more realistic expectations and
approaches. This conference, Online Marketing and eDetailing, organised by
eyeforpharma, showed significant evidence that physicians are at last embracing
online technology on a regular basis. The question of whether doctors are using
the internet can finally be laid to rest: studies show that between 70% and 97%
of European Union (EU) physicians use the internet on a daily basis for
accessing clinical information. [read more |
buy it]
Conference marketing: events,
exhibitions and sponsorship
Published by: Euromed Communications
Price: £20.00
Reprinted from the Medical Marketing Manual,
Mike Rea argues that ‘Conference marketing’ is set to remain a
central feature of every pharmaceutical brand plan, despite the explosion of
Internet-based physician contact. [read more |
buy
it]
Demonstrating
the value of medicines
Published by: Euromed Communications
Price:
£20.00
Reprinted from the Medical Marketing Manual Patrick
Hopkinson, Paul Trueman and Francois Schubert describe the fundamental changes
in the pharmaceutical market that are driving the need for companies to
demonstrate the value of new medicines. [read more
buy it]
Developing
Win-Win Key Opinion Leader Relationships
Published by: VirSci
Corporation
Price: £5.35
In today's health care industry, the
competition for the most respected, experienced physicians is heating up. This
is true not only for health care delivery organizations, it is also a challenge
for pharmaceutical companies seeking key opinion leaders (KOLs) to help them in
researching, launching, and marketing new drugs. KOLs offer valuable insights
into disease states and patient treatment regimens, in addition to new product
exposure through medical literature and their professional circles. [read
more |
buy it]
The future role of the sales force
Published by:
Euromed Communications
Price: £20.00
The pharmaceutical
industry is changing rapidly. Gone are the days where the products of Research
and Development were exposed somewhat reluctantly by their scientific champions
to the palette of marketing activity some 1-2 years before launch. Now, it is
essential that there is communication and co-operation between researchers,
clinical development experts and marketers. This collaboration must be
co-ordinated from the point of invention to patent expiry and beyond, to ensure
that long-term investment leads to tangible patient benefits so creating
competitive edge, payor acceptance and ultimately increasing shareholder value.
[read
more |
buy it]
Disclaimer
Net Media Marketing
excludes any warranty, express or implied, as to the quality, accuracy,
timeliness, completeness or fitness for a particular purpose of this briefing.
OnePharm Internet will not be liable for any claims, penalties, losses,
damages, costs, or expenses arising from the use of or inability to use this
briefing or from any unauthorised access to or alteration of the Briefing.
OnePharm Internet makes no warranty that the contents of this briefing are
compatible with all computer systems and browsers.
|
